- Report
- October 2024
- 190 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- January 2025
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 179 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- May 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 157 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- August 2023
- 285 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2024
- 113 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- October 2024
- 94 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- October 2022
- 274 Pages
Global
From €3394EUR$3,570USD£2,851GBP
Leukapheresis is a process used in hematology to separate white blood cells from other components of the blood. It is used to reduce the number of white blood cells in a patient's blood, which can be beneficial in the treatment of certain blood disorders. The process involves the use of a machine to separate the white blood cells from the other components of the blood, which are then returned to the patient. The white blood cells are then collected and stored for further use.
Leukapheresis is used in the treatment of a variety of hematological conditions, including leukemia, lymphoma, and multiple myeloma. It is also used to reduce the risk of infection in patients undergoing chemotherapy or bone marrow transplantation.
The leukapheresis market is composed of a variety of companies that provide products and services related to the process. These include companies that manufacture the machines used in the process, as well as those that provide the necessary supplies and services. Examples of companies in the leukapheresis market include Fresenius Medical Care, Haemonetics Corporation, Terumo BCT, and Asahi Kasei Medical. Show Less Read more